These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23484553)

  • 1. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.
    Kuhle J; Petzold A
    Expert Opin Med Diagn; 2011 Jul; 5(4):333-46. PubMed ID: 23484553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.
    Kuhle J; Petzold A
    Expert Opin Med Diagn; 2011 Sep; 5(5):393-410. PubMed ID: 23484626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury.
    Small DM; Gobe GC
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):655-64. PubMed ID: 22475359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic biomarker discovery: it's more than just mass spectrometry.
    Blonder J; Issaq HJ; Veenstra TD
    Electrophoresis; 2011 Jun; 32(13):1541-8. PubMed ID: 21557261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving role of biomarkers in acute cerebrovascular disease.
    Kernagis DN; Laskowitz DT
    Ann Neurol; 2012 Mar; 71(3):289-303. PubMed ID: 22451199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development.
    Dolled-Filhart MP; Gustavson MD
    Expert Opin Med Diagn; 2012 Nov; 6(6):569-83. PubMed ID: 23480838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers for improved prognostic accuracy in acute CNS disease.
    Petzold A
    Neurol Res; 2007 Oct; 29(7):691-708. PubMed ID: 18173909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-overcoming barriers in translating biomarkers to clinical practice.
    Staratschek-Jox A; Schultze JL
    Expert Opin Med Diagn; 2010 Mar; 4(2):103-12. PubMed ID: 23484444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics advances for clinical biomarker development.
    Pritzker KP; Pritzker LB
    Expert Opin Med Diagn; 2012 Jan; 6(1):39-48. PubMed ID: 23480619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arena.
    Currid CA; Gallagher WM
    Expert Opin Med Diagn; 2008 Sep; 2(9):1091-4. PubMed ID: 23495928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
    Naraoka H; Suzumura K; Takeuchi K; Sasayama T
    Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.
    Montaner J; García-Berrocoso T; Mendioroz M; Palacios M; Perea-Gainza M; Delgado P; Rosell A; Slevin M; Ribó M; Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2012; 34(3):240-5. PubMed ID: 23018289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.
    Jimenez CR; Piersma S; Pham TV
    Biomark Med; 2007 Dec; 1(4):541-65. PubMed ID: 20477373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel diagnostic and prognostic biomarkers in biliary tract cancer.
    Skipworth JR; Timms JF; Pereira SP
    Expert Opin Med Diagn; 2013 Sep; 7(5):487-99. PubMed ID: 23971898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.